Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Interactome Biotherapeutics Logo
Interactome Biotherapeutics CB Rank
728242
Heat Score
27
Interactome Biotherapeutics is an extracellular vesicle platform that offers proteins and factors crucial for cellular regeneration.
Founded
obfuscation
Private Chicago, Illinois, United States1-10 interactomebio.com
Biopharma
Biotechnology
Manufacturing
Overview

Interactome Biotherapeutics
Heat Score
27

Growth Score
pts
in past quarter
Heat Score 27
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Interactome Biotherapeutics

CB Rank
728242
Interactome Biotherapeutics is an extracellular vesicle platform that offers proteins and factors crucial for cellular regeneration.
Founded
obfuscation
Private Chicago, Illinois, United States1-10 interactomebio.com
Biopharma
Biotechnology
Manufacturing

Details

Legal Name Interactome Biotherapeutics
Operating Status Active
Company Type For Profit
Phone Number +1 773 919 5430
Contact Email support@interactomebio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

IB001
A small extracellular vesicle (sEV) therapeutic candidate targeting neuropathic pain.
IB003
A gene therapy and small extracellular vesicle (sEV) candidate for neuroimmunology applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 3
News

News and Press

News•Mar 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 10, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

84
12%
 in past month

IT Spend

$235KThis year, Interactome Biotherapeutics is projected to spend $235K on IT, according to Aberdeen.

Active Website Tech Count

3Interactome Biotherapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Interactome Biotherapeutics's headquarters? Interactome Biotherapeutics is located in Chicago, Illinois, United States.Who are Interactome Biotherapeutics's competitors? Alternatives and possible competitors to Interactome Biotherapeutics may include Silo Pharma, Capricor Therapeutics, and  Evox Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|